AxoGen, Inc.
AXGN
$43.20
$1.433.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 238.11M | 225.21M | 214.71M | 203.27M | 194.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 238.11M | 225.21M | 214.71M | 203.27M | 194.52M |
| Cost of Revenue | 59.50M | 57.86M | 54.19M | 52.31M | 50.23M |
| Gross Profit | 178.61M | 167.35M | 160.52M | 150.96M | 144.29M |
| SG&A Expenses | 153.32M | 142.32M | 129.37M | 122.61M | 118.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 247.13M | 233.06M | 210.77M | 201.56M | 194.91M |
| Operating Income | -9.02M | -7.85M | 3.94M | 1.71M | -388.00K |
| Income Before Tax | -31.45M | -15.70M | -2.10M | -4.66M | -7.16M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.45 | -15.70 | -2.10 | -4.66 | -7.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.45M | -15.70M | -2.10M | -4.66M | -7.16M |
| EBIT | -9.02M | -7.85M | 3.94M | 1.71M | -388.00K |
| EBITDA | -2.14M | -874.00K | 10.89M | 8.65M | 6.56M |
| EPS Basic | -0.63 | -0.34 | -0.05 | -0.10 | -0.16 |
| Normalized Basic EPS | -0.19 | -0.21 | -0.03 | -0.07 | -0.10 |
| EPS Diluted | -0.64 | -0.35 | -0.05 | -0.11 | -0.16 |
| Normalized Diluted EPS | -0.19 | -0.21 | -0.03 | -0.07 | -0.10 |
| Average Basic Shares Outstanding | 191.08M | 184.69M | 182.64M | 180.03M | 177.68M |
| Average Diluted Shares Outstanding | 195.59M | 189.20M | 190.34M | 185.13M | 180.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |